Henry Havel, PhD
Dr. Henry Havel is a skilled pharmaceutical development scientist with more than 35 years experience working on projects from discovery to launch. He recently retired from his position as a Senior Research Fellow at Eli Lilly and Company and is now a Chemistry, Manufacturing, and Control (CMC) consultant to small and large companies.
During Dr. Havel’s career, he applied his knowledge and expertise to characterization, delivery, and development of small molecule, peptide and protein therapeutics. He has considerable experience in due diligence, intellectual property, and the emerging field of nanomedicine. Prior to joining Lilly, Dr. Havel worked at The Upjohn Company (now Pfizer) in Kalamazoo, Michigan. He holds a Ph.D. from the University of Minnesota and a B.S. from the University of Rochester, both in chemistry.